中华医学杂志（英文版）2025，Vol.138Issue(12)：1477-1486,10.DOI:10.1097/CM9.0000000000003151
Abemaciclib plus non-steroidal aromatase inhibitor or fulvestrant in women with HR+/HER2-advanced breast cancer:Final results of the randomized phase Ⅲ MONARCH plus trial
Abemaciclib plus non-steroidal aromatase inhibitor or fulvestrant in women with HR+/HER2-advanced breast cancer:Final results of the randomized phase Ⅲ MONARCH plus trial
摘要
关键词
Abemaciclib/Advanced breast cancer/Cyclin-dependent kinase 4/6 inhibitor/Progression-free survival/MONARCH plusKey words
Abemaciclib/Advanced breast cancer/Cyclin-dependent kinase 4/6 inhibitor/Progression-free survival/MONARCH plus引用本文复制引用
..Abemaciclib plus non-steroidal aromatase inhibitor or fulvestrant in women with HR+/HER2-advanced breast cancer:Final results of the randomized phase Ⅲ MONARCH plus trial[J].中华医学杂志（英文版）,2025,138(12):1477-1486,10.
